Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and/or Zileuton with Chemotherapy in Advanced NSCLC
NCT00070486Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2003
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution, zileuton extended release in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Started Dec 2003; status: completed.
02
Drugs
celecoxib oral solutionzileuton extended release
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00070486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070486.